Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Phase 1
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Biological: Recombinant full human Anti-EGFR Monoclonal Antibody
- First Posted Date
- 2014-08-07
- Last Posted Date
- 2015-04-09
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 21
- Registration Number
- NCT02211443
Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.
Phase 1
Completed
- Conditions
- B-cell Non Hodgkin's Lymphoma
- Interventions
- Biological: Chimeric anti-CD20 monoclonal antibody
- First Posted Date
- 2014-08-01
- Last Posted Date
- 2014-08-01
- Lead Sponsor
- Sinocelltech Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT02206308
© Copyright 2025. All Rights Reserved by MedPath